In Vivo Pharmacokinetic Evaluation of a Gastro-retentive Triple Drug Delivery System Utilizing Natural Polymers for Enhanced Helicobacter pylori Eradication
Open Access
- 14 November 2025
- journal article
- Published by Faculty of Pharmacy Cairo University in Bulletin of Faculty of Pharmacy Cairo University
- Vol. 63 (2) , 6
Abstract
This study evaluates the in vivo pharmacokinetics of triple-drug gastro-retentive formulation (metronidazole- Plantago ovata seed mucilage/ clarithromycin- Abelmoschus esculentus fruit mucilage/enteric-coated pantoprazole) for Helicobacter pylori eradication, with a focus on pharmacokinetic parameters (e.g., relative bioavailability vs. conventional doses) as the true contribution. In a cross over study using six rabbits, plasma concentrations of metronidazole, clarithromycin, and pantoprazole sodium were measured via High Performance Liquid Chromatography technique, and pharmacokinetic parameters were determined. A single dose of the optimized formulation (C-8) produced optimal drug levels, with a mean Cmax of 24.36 ± 0.84 μg/mL and tmax at 6 hours. The other pharmacokinetic results were found to be satisfactory. These results suggest that the optimized formula (C-8) offers effective systemic delivery with favorable pharmacokinetics, potentially improving compliance in Helicobacter pylori treatment regimens.Keywords
This publication has 29 references indexed in Scilit:
- Single-dose oral administration of drug-loaded magnetic 3D-printed microbullets for eradication of Helicobacter pyloriAsian Journal of Pharmaceutical Sciences, 2025
- Advancements in Drug Delivery Systems: A Focus on Microsphere-Based Targeted DeliveryBiomedical Materials & Devices, 2024
- Cadmium and lead-induced Bacoside-A production, genetic responses, biomass enhancement, and antioxidant defense in Bacopa monnieri (L.) Wettst.: A comparative analysisIndustrial Crops and Products, 2024
- Design and preparation of hydrogel microspheres for spinal cord injury repairJournal of Biomedical Materials Research Part A, 2024
- Advances in micro/nanodrug delivery systems for the treatment of Helicobacter pylori infection: From diagnosis to eradicationApplied Materials Today, 2024
- H+/K+ATPase Expression in the Larynx of Laryngopharyngeal Reflux and Laryngeal Cancer PatientsThe Laryngoscope, 2020
- Structural Aspects of Helicobacter pylori Antibiotic Resistance2019
- Dose translation between laboratory animals and human in preclinical and clinical phases of drug developmentDrug Development Research, 2018
- Helicobacter pylori Clarithromycin Resistance and Treatment Failure Are Common in the USADigestive Diseases and Sciences, 2016
- Gastroretentive dosage forms: Overview and special case of Helicobacter pyloriJournal of Controlled Release, 2006